Corrigendum for “Potent nanoreactor-mediated ferroptosis-based strategy for the reversal of cancer chemoresistance to Sorafenib” [Acta Biomaterialia, 2023, 159, 237-246]
Titel:
Corrigendum for “Potent nanoreactor-mediated ferroptosis-based strategy for the reversal of cancer chemoresistance to Sorafenib” [Acta Biomaterialia, 2023, 159, 237-246]